Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights into Regulators of p53 Acetylation. | Cells | 2022 | 36497084 | PubTator, text mining | PubMed |
| New Insights into Mechanisms of Ferroptosis Associated with Immune Infiltration in Neonatal Hypoxic-Ischemic Brain Damage. | Cells | 2022 | 36497037 | PubTator, text mining | PubMed |
| Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. | Sci Adv | 2022 | 36490346 | PubTator, text mining | PubMed |
| CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance. | Int J Med Sci | 2022 | 36483595 | PubTator, text mining | PubMed |
| METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10. | Cancer Cell Int | 2022 | 36476503 | PubTator, text mining | PubMed |
| MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30. | Cell Mol Biol Lett | 2022 | 36474192 | PubTator, text mining | PubMed |
| Targeting ferroptosis, the achilles' heel of breast cancer: A review. | Front Pharmacol | 2022 | 36467032 | PubTator, text mining | PubMed |
| Expansion of the mutation spectrum and phenotype of USP7-related neurodevelopmental disorder. | Front Mol Neurosci | 2022 | 36466803 | PubTator, text mining | PubMed |
| A review of recent advances in plant-pathogen detection systems. | Heliyon | 2022 | 36466579 | PubTator, text mining | PubMed |
| Extracellular RNA as a kind of communication molecule and emerging cancer biomarker. | Front Oncol | 2022 | 36465402 | PubTator, text mining | PubMed |
| Targeting inflammasome-dependent mechanisms as an emerging pharmacological approach for osteoarthritis therapy. | iScience | 2022 | 36465135 | PubTator, text mining | PubMed |
| The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 | 36456881 | PubTator, text mining | PubMed |
| Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer. | J Med Chem | 2022 | 36454192 | PubTator, text mining | PubMed |
| Analysis of m6A modulator-mediated methylation modification patterns and the tumor microenvironment in lung adenocarcinoma. | Sci Rep | 2022 | 36450735 | PubTator, text mining | PubMed |
| Biological roles of the RNA m6A modification and its implications in cancer. | Exp Mol Med | 2022 | 36446846 | PubTator, text mining | PubMed |
| Modulatory Effect of Chlorogenic Acid and Coffee Extracts on Wnt/β-Catenin Pathway in Colorectal Cancer Cells. | Nutrients | 2022 | 36432565 | PubTator, text mining | PubMed |
| The Four Homeostasis Knights: In Balance upon Post-Translational Modifications. | Int J Mol Sci | 2022 | 36430960 | PubTator, text mining | PubMed |
| Epstein-Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments. | Int J Mol Sci | 2022 | 36430864 | PubTator, text mining | PubMed |
| Targeting Multiple Homeostasis-Maintaining Systems by Ionophore Nigericin Is a Novel Approach for Senolysis. | Int J Mol Sci | 2022 | 36430735 | PubTator, text mining | PubMed |
| Targeting PTEN Regulation by Post Translational Modifications. | Cancers (Basel) | 2022 | 36428706 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=44